• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cu-螯合型和 ROS 清除型 MX 酶作为近红外二区触发的血脑屏障穿透纳米催化剂用于治疗阿尔茨海默病。

Cu -Chelatable and ROS-Scavenging MXenzyme as NIR-II-Triggered Blood-Brain Barrier-Crossing Nanocatalyst against Alzheimer's Disease.

机构信息

Department of Radiology, Huashan Hospital, National Center for Neurological Disorders, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, 200040, P. R. China.

Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.

出版信息

Small. 2022 Sep;18(39):e2203031. doi: 10.1002/smll.202203031. Epub 2022 Aug 25.

DOI:10.1002/smll.202203031
PMID:36008124
Abstract

Transition-metal dyshomeostasis has been identified as a critical pathogenic factor for the aggregates of amyloid-beta (Aβ) peptide, which is associated with the onset and progression of Alzheimer's disease (AD). Excessive transition-metal ions, especially copper ion (Cu ), catalyze the formation of reactive oxygen species (ROS), triggering neuroinflammation and neuronal cell apoptosis. Therefore, developing a robust chelating agent can not only efficiently bind toxic Cu , but also simultaneously scavenge the over-generated ROS that is urgently needed for AD treatment. In this work, a 2D niobium carbide (Nb C) MXene-based nano-chelator is constructed and its performance in suppressing Cu -induced accumulation of aggregated Aβ peptide and acting as a nanozyme (MXenzyme) with powerful antioxidant property to scavenge excess cellular ROS is explored, and the intrinsic mechanism is revealed by computational simulation. Importantly, the benign photothermal effect of Nb C MXenzyme demonstrates the facilitated permeability of the blood-brain barrier under near-infrared laser irradiation, conquering limitations of the most conventional anti-AD therapeutic agents. This work not only demonstrates a favorable strategy for combating AD by engineering Nb C MXenzyme-based neuroprotective nano-chelator, but also paves a distinct insight for extending the biomedical applications of MXenes in treating transition-metal dyshomeostasis-and ROS-mediated central nervous system diseases.

摘要

过渡金属稳态失衡已被确定为淀粉样β(Aβ)肽聚集的关键致病因素,与阿尔茨海默病(AD)的发病和进展有关。过量的过渡金属离子,特别是铜离子(Cu ),会催化活性氧物质(ROS)的形成,引发神经炎症和神经元细胞凋亡。因此,开发一种强大的螯合剂不仅可以有效地结合有毒的 Cu ,还可以同时清除 AD 治疗急需的过量生成的 ROS。在这项工作中,构建了一种二维碳化铌(NbC)MXene 基纳米螯合剂,并探索了其抑制 Cu 诱导的聚集 Aβ肽积累的性能,以及作为具有强大抗氧化性能的纳米酶(MXenzyme)来清除过量细胞 ROS 的性能,通过计算模拟揭示了其内在机制。重要的是,NbC MXenzyme 的良性光热效应证明了在近红外激光照射下血脑屏障通透性的增加,克服了大多数传统抗 AD 治疗剂的局限性。这项工作不仅展示了通过工程化 NbC MXenzyme 基神经保护纳米螯合剂来对抗 AD 的有利策略,而且为扩展 MXenes 在治疗过渡金属稳态失衡和 ROS 介导的中枢神经系统疾病中的生物医学应用提供了独特的见解。

相似文献

1
Cu -Chelatable and ROS-Scavenging MXenzyme as NIR-II-Triggered Blood-Brain Barrier-Crossing Nanocatalyst against Alzheimer's Disease.Cu-螯合型和 ROS 清除型 MX 酶作为近红外二区触发的血脑屏障穿透纳米催化剂用于治疗阿尔茨海默病。
Small. 2022 Sep;18(39):e2203031. doi: 10.1002/smll.202203031. Epub 2022 Aug 25.
2
Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.具有加速淀粉样β-Cu 纤维降解和降低毒性潜力的双功能肽在阿尔茨海默病模型大鼠中的药效学研究。
Acta Biomater. 2018 Jan;65:327-338. doi: 10.1016/j.actbio.2017.10.039. Epub 2017 Oct 27.
3
The redox chemistry of the Alzheimer's disease amyloid beta peptide.阿尔茨海默病淀粉样β肽的氧化还原化学
Biochim Biophys Acta. 2007 Aug;1768(8):1976-90. doi: 10.1016/j.bbamem.2007.02.002. Epub 2007 Feb 9.
4
Gold nanoparticle-capped mesoporous silica-based HO-responsive controlled release system for Alzheimer's disease treatment.用于阿尔茨海默病治疗的金纳米颗粒包覆的介孔二氧化硅基过氧化氢响应型控释系统。
Acta Biomater. 2016 Dec;46:177-190. doi: 10.1016/j.actbio.2016.09.010. Epub 2016 Sep 9.
5
Power of Dopamine: Multifunctional Compound Assisted Conversion of the Most Risk Factor into Therapeutics of Alzheimer's Disease.多巴胺的力量:多功能化合物辅助将最大风险因素转化为阿尔茨海默病的治疗方法。
ACS Chem Neurosci. 2024 Jul 3;15(13):2470-2483. doi: 10.1021/acschemneuro.3c00777. Epub 2024 Jun 14.
6
Biofilm-camouflaged Prussian blue synergistic mitochondrial mass enhancement for Alzheimer's disease based on Cu chelation and photothermal therapy.基于铜螯合和光热疗法的生物膜伪装普鲁士蓝协同增强线粒体质量治疗阿尔茨海默病
J Control Release. 2024 Nov;375:269-284. doi: 10.1016/j.jconrel.2024.09.009. Epub 2024 Sep 13.
7
The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.正在寻找小分子以研究阿尔茨海默病中与金属相关的淀粉样-β 物种。
Acc Chem Res. 2014 Aug 19;47(8):2475-82. doi: 10.1021/ar500152x. Epub 2014 Jul 31.
8
CeO In Situ Growth on Red Blood Cell Membranes: CQD Coating and Multipathway Alzheimer's Disease Therapy under NIR.氧化铈在红细胞膜上的原位生长:近红外光下的碳量子点涂层与多途径阿尔茨海默病治疗
ACS Appl Mater Interfaces. 2024 Jul 17;16(28):35898-35911. doi: 10.1021/acsami.4c02088. Epub 2024 Jul 2.
9
Peptide-Functionalized Prussian Blue Nanomaterial for Antioxidant Stress and NIR Photothermal Therapy against Alzheimer's Disease.肽功能化普鲁士蓝纳米材料用于抗氧化应激和近红外光热疗治疗阿尔茨海默病。
Small. 2023 Oct;19(41):e2206959. doi: 10.1002/smll.202206959. Epub 2023 Jun 15.
10
Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions.超薄碳化铌 MX 酶通过抗氧化和神经保护作用治疗高血压。
Angew Chem Int Ed Engl. 2023 Jun 26;62(26):e202303539. doi: 10.1002/anie.202303539. Epub 2023 May 15.

引用本文的文献

1
Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension.从肺动脉高压角度看铁死亡与铜死亡的相互作用
Front Cardiovasc Med. 2025 Jun 26;12:1611449. doi: 10.3389/fcvm.2025.1611449. eCollection 2025.
2
Broad-spectrum antioxidant and neuroprotective Prussian blue nanocatalyst for therapeutic intervention in autism spectrum disorder.用于自闭症谱系障碍治疗干预的广谱抗氧化和神经保护普鲁士蓝纳米催化剂。
Redox Biol. 2025 Jul;84:103671. doi: 10.1016/j.redox.2025.103671. Epub 2025 May 17.
3
Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases.
纳米酶:对抗神经退行性疾病的创新疗法
Int J Mol Sci. 2025 Apr 9;26(8):3522. doi: 10.3390/ijms26083522.
4
Inhibition of the cGAS-STING pathway an endogenous copper ion-responsive covalent organic framework nanozyme for Alzheimer's disease treatment.抑制cGAS-STING通路:一种用于治疗阿尔茨海默病的内源性铜离子响应性共价有机框架纳米酶
Chem Sci. 2025 Mar 11;16(17):7215-7226. doi: 10.1039/d4sc07963a. eCollection 2025 Apr 30.
5
Nanozymes: a promising solution for dental antibacterial applications.纳米酶:牙科抗菌应用的一种有前景的解决方案。
RSC Adv. 2024 Nov 20;14(50):36945-36959. doi: 10.1039/d4ra07303g. eCollection 2024 Nov 19.
6
Copper homeostasis and cuproptosis in central nervous system diseases.中枢神经系统疾病中的铜稳态和铜死亡。
Cell Death Dis. 2024 Nov 21;15(11):850. doi: 10.1038/s41419-024-07206-3.
7
Recent advances in two-dimensional materials for the diagnosis and treatment of neurodegenerative diseases.用于神经退行性疾病诊断和治疗的二维材料的最新进展。
Discov Nano. 2024 Sep 17;19(1):151. doi: 10.1186/s11671-024-04099-1.
8
A biomimetic upconversion nanoreactors for near-infrared driven H release to inhibit tauopathy in Alzheimer's disease therapy.一种用于近红外驱动氢释放以抑制阿尔茨海默病治疗中tau蛋白病的仿生上转换纳米反应器。
Bioact Mater. 2024 Aug 30;42:165-177. doi: 10.1016/j.bioactmat.2024.08.029. eCollection 2024 Dec.
9
Niobium carbide MXenzyme-Driven comprehensive cholesterol regulation for photoacoustic image-guided and anti-inflammatory photothermal ablation in atherosclerosis.碳化铌MX酶驱动的全面胆固醇调节,用于动脉粥样硬化的光声成像引导和抗炎光热消融。
Bioact Mater. 2024 Jul 5;36:565-579. doi: 10.1016/j.bioactmat.2024.07.001. eCollection 2024 Jun.
10
SIRT1-regulated ROS generation activates NMDAR2B phosphorylation to promote central sensitization and allodynia in a male chronic migraine rat model.在雄性慢性偏头痛大鼠模型中,SIRT1调节的活性氧生成激活NMDAR2B磷酸化,以促进中枢敏化和异常性疼痛。
Front Mol Neurosci. 2024 May 22;17:1387481. doi: 10.3389/fnmol.2024.1387481. eCollection 2024.